Vanguard Group
ACGN

Vanguard Group’s Aceragen Inc ACGN Stock Holding History

Vanguard Group’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-74,170
Closed -$121K – 4596
2023
Q2 		$121K Sell
74,170
-1,888
-2% -$3.5K ﹤0.01% 4374
2023
Q1 		$174K Buy
76,058
+1,484
+2% +$7.76K ﹤0.01% 4337
2022
Q4 		$444K Sell
74,574
-20
-0% -$120 ﹤0.01% 4129
2022
Q3 		$474K Sell
74,594
-3,596
-5% -$27.1K ﹤0.01% 4229
2022
Q2 		$609K Buy
78,190
+11
+0% +$94 ﹤0.01% 4233
2022
Q1 		$664K Sell
78,179
-14,658
-16% -$133K ﹤0.01% 4326
2021
Q4 		$899K Buy
92,837
+5,967
+7% +$80K ﹤0.01% 4291
2021
Q3 		$1.52M Sell
86,870
-106
-0.1% -$1.91K ﹤0.01% 4139
2021
Q2 		$1.77M Buy
86,976
+12,102
+16% +$244K ﹤0.01% 4000
2021
Q1 		$1.65M Buy
74,874
+14,738
+25% +$1.1M ﹤0.01% 3908
2020
Q4 		$3.75M Buy
60,136
+3,163
+6% +$181K ﹤0.01% 3483
2020
Q3 		$2.07M Sell
56,973
-1,460
-2% -$51.8K ﹤0.01% 3476
2020
Q2 		$1.78M Hold
58,433
– – ﹤0.01% 3462
2020
Q1 		$1.31M Hold
58,433
– – ﹤0.01% 3426
2019
Q4 		$1.81M Hold
58,433
– – ﹤0.01% 3479
2019
Q3 		$2.87M Buy
58,433
+810
+1% +$35.6K ﹤0.01% 3326
2019
Q2 		$2.61M Buy
57,623
+1,483
+3% +$70.2K ﹤0.01% 3392
2019
Q1 		$2.43M Buy
56,140
+27,764
+98% +$1.34M ﹤0.01% 3385
2018
Q4 		$1.33M Sell
28,376
-29,792
-51% -$3.42M ﹤0.01% 3480
2018
Q3 		$8.8M Sell
58,168
-433
-0.7% -$61.8K ﹤0.01% 2979
2018
Q2 		$10.5M Buy
58,601
+6,438
+12% +$1.5M ﹤0.01% 2878
2018
Q1 		$13M Buy
52,163
+3,517
+7% +$965K ﹤0.01% 2690
2017
Q4 		$13.9M Buy
48,646
+8,642
+22% +$2.47M ﹤0.01% 2668
2017
Q3 		$12.1M Buy
40,004
+1,870
+5% +$489K ﹤0.01% 2719
2017
Q2 		$8.91M Buy
38,134
+1,279
+3% +$334K ﹤0.01% 2834
2017
Q1 		$12.4M Buy
36,855
+1,176
+3% +$284K ﹤0.01% 2666
2016
Q4 		$7.27M Buy
35,679
+7,407
+26% +$1.77M ﹤0.01% 2885
2016
Q3 		$9.83M Buy
28,272
+1,934
+7% +$512K ﹤0.01% 2694
2016
Q2 		$5.47M Sell
26,338
-646
-2% -$142K ﹤0.01% 2931
2016
Q1 		$7.26M Buy
26,984
+1,266
+5% +$338K ﹤0.01% 2782
2015
Q4 		$10.8M Buy
25,718
+56
+0.2% +$25.1K ﹤0.01% 2594
2015
Q3 		$11.7M Buy
25,662
+2,029
+9% +$897K ﹤0.01% 2525
2015
Q2 		$11.9M Buy
23,633
+1,292
+6% +$593K ﹤0.01% 2579
2015
Q1 		$11.3M Buy
22,341
+5,151
+30% +$3.14M ﹤0.01% 2592
2014
Q4 		$10.3M Buy
17,190
+121
+0.7% +$48.5K ﹤0.01% 2525
2014
Q3 		$5.31M Buy
17,069
+1,516
+10% +$546K ﹤0.01% 2792
2014
Q2 		$6.13M Buy
15,553
+2,263
+17% +$933K ﹤0.01% 2741
2014
Q1 		$7.37M Buy
13,290
+5,273
+66% +$3.61M ﹤0.01% 2632
2013
Q4 		$5.04M Buy
8,017
+7,883
+5,883% +$2.63M ﹤0.01% 2799
2013
Q3 		$31K Hold
134
– – ﹤0.01% 3823
2013
Q2 		$11K Buy
+134
New +$12.1K ﹤0.01% 3793

Other funds holding ACGN

PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Vanguard Group's ACGN Position: Q3 2023 in Review

Vanguard Group sold out of Aceragen Inc (ACGN) in Q3 2023, closing a stake of 74,170 shares — an estimated $121K sold.

Vanguard Group first reported a position in ACGN in Q2 2013 and held it in 41 quarters. The position peaked at $13.9M in Q4 2017. 3 funds tracked by Wall St. Rank hold ACGN as of Q3 2023.

  • Vanguard Group reported no remaining Aceragen Inc position as of Q3 2023 after selling out during the quarter.
  • Vanguard Group sold 74,170 Aceragen Inc shares in Q3 2023, an estimated $121K.
  • Vanguard Group first reported a position in Aceragen Inc in Q2 2013 and held it in 41 quarters.
  • Vanguard Group's Aceragen Inc position peaked at $13.9M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2023.

Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.